Al B. Benson, MD, FACP
Robert H. Lurie Cancer Center
7
0
6
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jaffer A. Ajani, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Michael G. Haddock, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
John S. MacDonald, MD
Beth Israel Comprehensive Cancer Center - West Side Campus
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Anthony LA Fields, MD, FRCPC
Cross Cancer Institute at University of Alberta
Shared therapeutic areas:
Worked with same sponsors:
Michael J. O'Connell, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Robert J. Mayer, MD, FACP
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
All 7 trials loaded